Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Amy GilesIncreasing Engagement
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
Matt TurnerPatient Affordability
Joey CohenMedication Adherence
Zilretta™, Flexion’s non-opioid lead drug candidate (also known as FX006), completed pivotal Phase 2b ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email